Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

Cedric J Rutland,1 Onyinye I Iweala,2 Kyle Anders,3 Jinnie Ko,3 Parul Mital,3 Sachin Gupta,3 Arjun Mohan4 1Rutland Medical Group, Newport Beach, CA, USA; 2Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA; 3Genentech, Inc., South San Francisco, CA,...

Full description

Bibliographic Details
Main Authors: Rutland CJ, Iweala OI, Anders K, Ko J, Mital P, Gupta S, Mohan A
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:Journal of Asthma and Allergy
Subjects:
antitussive
asthma
cough
omalizumab
Online Access:https://www.dovepress.com/antitussive-use-in-patients-with-inadequately-controlled-moderate-to-s-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/antitussive-use-in-patients-with-inadequately-controlled-moderate-to-s-peer-reviewed-fulltext-article-JAA

Similar Items